Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Arista Networks
ANET
|
$246M |
| 2 |
Lam Research
LRCX
|
$236M |
| 3 |
Spotify
SPOT
|
$189M |
| 4 |
Palo Alto Networks
PANW
|
$160M |
| 5 |
Tractor Supply
TSCO
|
$63.9M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$500M |
| 2 |
Microsoft
MSFT
|
$426M |
| 3 |
Amazon
AMZN
|
$245M |
| 4 |
Meta Platforms (Facebook)
META
|
$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$167M |
Sector Composition
| 1 | Technology | 33.9% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Healthcare | 10.7% |
| 4 | Communication Services | 9.68% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Montauk Renewables
MNTK
$306M
| $338K | ﹤0.01% | 84,977 -14,023 | -14% | -$55.8K |
|
|
RAPP
2427
Rapport Therapeutics
RAPP
$643M
| $319K | ﹤0.01% | +18,000 | New | +$319K |
|
2428
Lexicon Pharmaceuticals
LXRX
$400M
| $315K | ﹤0.01% | 426,600 +109,100 | +34% | +$80.6K |
|
2429
Dianthus Therapeutics
DNTH
$759M
| $314K | ﹤0.01% | 14,400 -2,900 | -17% | -$63.2K |
|
2430
Crawford & Co Class A
CRD.A
$538M
| $311K | ﹤0.01% | 26,874 -4,726 | -15% | -$54.6K |
|
2431
Liberty Latin America Class A
LILA
$1.61B
| $301K | ﹤0.01% | 47,369 -13,031 | -22% | -$82.9K |
|
2432
Tango Therapeutics
TNGX
$747M
| $293K | ﹤0.01% | 94,900 +11,000 | +13% | +$34K |
|
2433
Tyra Biosciences
TYRA
$675M
| $288K | ﹤0.01% | 20,700 -5,000 | -19% | -$69.5K |
|
2434
4D Molecular Therapeutics
FDMT
$288M
| $281K | ﹤0.01% | 50,500 | – | – |
|
2435
Perspective Therapeutics
CATX
$250M
| $275K | ﹤0.01% | 86,260 -5,900 | -6% | -$18.8K |
|
2436
Alector
ALEC
$238M
| $249K | ﹤0.01% | 131,900 | – | – |
|
2437
Omega Flex
OFLX
$356M
| $239K | ﹤0.01% | 5,703 -1,297 | -19% | -$54.4K |
|
2438
Cassava Sciences
SAVA
$110M
| $210K | ﹤0.01% | 89,000 | – | – |
|
2439
Applied Therapeutics
APLT
$71M
| $126K | ﹤0.01% | +146,900 | New | +$126K |
|
2440
Angi Inc
ANGI
$786M
| $115K | ﹤0.01% | 69,100 -71,100 | -51% | -$118K |
|
2441
Allient
ALNT
$769M
| – | – | -28,054 | Closed | -$533K |
|
2442
AMC Networks
AMCX
$306M
| – | – | -60,400 | Closed | -$525K |
|
2443
Berry Corp
BRY
$259M
| – | – | -143,800 | Closed | -$739K |
|
|
CLCO
2444
Cool Company
CLCO
$428M
| – | – | -47,888 | Closed | -$540K |
|
2445
America's Car Mart
CRMT
$371M
| – | – | -14,400 | Closed | -$604K |
|
2446
CryoPort
CYRX
$444M
| – | – | -96,300 | Closed | -$781K |
|
2447
Designer Brands
DBI
$181M
| – | – | -88,000 | Closed | -$649K |
|
2448
3D Systems Corporation
DDD
$295M
| – | – | -263,150 | Closed | -$747K |
|
2449
Denny's
DENN
$235M
| – | – | -99,500 | Closed | -$642K |
|
2450
Eventbrite
EB
$256M
| – | – | -123,200 | Closed | -$336K |
|